LON:SIS

Science in Sport Share Forecast, Price & News

GBX 80.22

-0.78 (-0.96 %)

(As of 06/17/2021 04:07 PM ET)

Add

Compare

Today's Range

80.13

▼

50-Day Range

▼

52-Week Range

▼

Volume194,615 shs

Average Volume351,506 shs

Market Capitalization£108.38 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive SIS News and Ratings via Email

Sign-up to receive the latest news and ratings for Science in Sport and its competitors with MarketBeat's FREE daily newsletter.

About Science in Sport

Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, and sports and fitness enthusiasts. The company offers energy bars, gels, powders, and shots; hydration products; recovery products; protein products; supplements; and vitamins and minerals. It sells its products under the PhD Nutrition and Science in Sport brand names through various retail channels, including traditional and online supermarkets and high street chains; specialist sports retailers; e-commerce sites; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as through its websites in the United Kingdom, rest of Europe, Australia, and internationally. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.

Here's What Science in Sport plc's (LON:SIS) Shareholder Ownership Structure Looks Like
June 16, 2021 | finance.yahoo.com

All In On Five: Sheryl Swoopes is frustrated Houston doesn't have WNBA team, would love league to expand
June 11, 2021 | msn.com

TikTok Is Going Crazy for This Simple Sleep Hack That Puts People to Sleep in Minutes
June 3, 2021 | msn.com

Clubhouse Funds Slate Of Original Audio Pilots
May 7, 2021 | msn.com

Clubhouse Moves Into Original Audio Series With Pilot Season
May 5, 2021 | msn.com

Broncos 2021 Third Round NFL Draft Board
April 28, 2021 | msn.com

If You Had Bought Science in Sport (LON:SIS) Shares A Year Ago You'd Have Earned 77% Returns
March 18, 2021 | finance.yahoo.com

SCIENCE IN SPORT PLC ORD 10P (LSE:SIS)
February 7, 2021 | fool.co.uk

Science in Sport PLC - Capital Markets Day
January 29, 2021 | proactiveinvestors.com

Orlando Magic shares more about planned downtown training facility
January 25, 2021 | bizjournals.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange LON
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolLON:SIS
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.scienceinsport.com
Phone+44-1282-440980
Employees176
Year FoundedN/A

Sales & Book Value

Annual Sales£50.35 million
Price / Sales2.15
Cash FlowGBX 7.78 per share
Price / Cash Flow10.32
Book ValueGBX 36.10 per share
Price / Book2.22

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares135,101,000
Market Cap£108.38 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.41 out of 5 stars

2.5 Analyst's Opinion

Consensus Rating
Science in Sport has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 100, Science in Sport has a forecasted upside of 24.7% from its current price of GBX 80.22.
Amount of Analyst Coverage
Science in Sport has only been the subject of 1 research reports in the past 90 days.

2.9 Community Rank

Outperform Votes
Science in Sport has received 132 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Science in Sport has received 98 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Science in Sport has received 57.39% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Science in Sport and other stocks. Vote “Outperform” if you believe SIS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SIS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Science in Sport does not currently pay a dividend.
Dividend Growth
Science in Sport does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Science in Sport insiders have bought more of their company's stock than they have sold. Specifically, they have bought £33,327.65 in company stock and sold GBX 0 in company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Science in Sport is -61.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Science in Sport is -61.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Science in Sport has a P/B Ratio of 2.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Science in Sport (LON:SIS) Frequently Asked Questions

Is Science in Sport a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Science in Sport in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Science in Sport stock.
View analyst ratings for Science in Sport or view top-rated stocks.

What stocks does MarketBeat like better than Science in Sport?

Wall Street analysts have given Science in Sport a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Science in Sport wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Science in Sport's earnings last quarter?

Science in Sport plc (LON:SIS) released its quarterly earnings data on Wednesday, September, 16th. The company reported ($1.80) earnings per share (EPS) for the quarter.
View Science in Sport's earnings history.

How has Science in Sport's stock been impacted by COVID-19?

Science in Sport's stock was trading at GBX 41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SIS shares have increased by 95.7% and is now trading at GBX 80.22.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for SIS?

1 equities research analysts have issued 1 year price targets for Science in Sport's shares. Their forecasts range from GBX 100 to GBX 100. On average, they expect Science in Sport's stock price to reach GBX 100 in the next twelve months. This suggests a possible upside of 24.7% from the stock's current price.
View analysts' price targets for Science in Sport or view top-rated stocks among Wall Street analysts.

Who are Science in Sport's key executives?

Science in Sport's management team includes the following people:

Mr. Stephen N. Moon, CEO & Exec. Director
Mr. James Lonsdale Simpson, CFO & Exec. Director (Age 47, Pay $174k)
Mr. Ashley Read, Chief Operating Officer
Muna Khan, Chief Technology Officer

Who are some of Science in Sport's key competitors?

Some companies that are related to Science in Sport include Benchmark (BMK), Amryt Pharma (AMYT), The Supreme Cannabis (FIRE), ICC Labs (ICC), The Green Organic Dutchman (TGOD), ESSA Pharma (EPI), Venture Life Group (VLG), Shield Therapeutics (STX), Diurnal Group (DNL), WeedMD (WMD), Delta 9 Cannabis (NINE), Acerus Pharmaceuticals (ASP), The Flowr (FLWR), BioSyent (RX) and Cipher Pharmaceuticals (CPH).
View all of SIS's competitors.

What other stocks do shareholders of Science in Sport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Science in Sport investors own include Cidara Therapeutics (CDTX), Carnival Co. & (CCL), Bellway (BWY), British American Tobacco (BTI), boohoo group (BOO), B&M European Value Retail (BME), Balfour Beatty (BBY), Alibaba Group (BABA), Advanced Oncotherapy (AVO) and ASOS (ASC).

What is Science in Sport's stock symbol?

Science in Sport trades on the London Stock Exchange (LON) under the ticker symbol "SIS."

How do I buy shares of Science in Sport?

Shares of SIS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Science in Sport's stock price today?

One share of SIS stock can currently be purchased for approximately GBX 80.22.

How much money does Science in Sport make?

Science in Sport has a market capitalization of £108.38 million and generates £50.35 million in revenue each year.

How many employees does Science in Sport have?

Science in Sport employs 176 workers across the globe.

What is Science in Sport's official website?

The official website for Science in Sport is www.scienceinsport.com.

Where are Science in Sport's headquarters?

Science in Sport is headquartered at 16-18 Hatton Garden, LONDON, EC1N 8AT, United Kingdom.

How can I contact Science in Sport?

Science in Sport's mailing address is 16-18 Hatton Garden, LONDON, EC1N 8AT, United Kingdom. The company can be reached via phone at +44-1282-440980.

This page was last updated on 6/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here